ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - December 12, 2019 Category: Cancer & Oncology Authors: Guru Sonpavde Andrea Necchi Shilpa Gupta Gary D Steinberg Juergen E Gschwend Michiel Simon Van Der Heijden Nathalie Garzon Mohammed Ibrahim Bradley Raybold Danny Liaw Mark Rutstein Matt D Galsky Source Type: research